Form D · Pharmaceuticals
KADMUS PHARMACEUTICALS INC
San Mateo, CA · CIK 0001163571
Offering snapshot reported Aug 24, 2009 · SEC filing
- Reported sold
- $300K Offering amount: $1.25M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 3, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2009 | Initial | $300,000 | No comparison | 6 | SEC filing |
| Nov 2, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 4, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-48380
Source: Form D, filed Aug 24, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Annette Bianchi | Director |
| Jeff Courtney | Director |
| Robert Mc Neil | Director |
| Dan O'connell | Director |
| Patrick D. Walsh | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
400 S. El Camino Real Suite 1200
San Mateo, CA, 94402
San Mateo, CA, 94402